Visit www.eventually.be for an absolutely moving experience about loss and grieving.
Something we hope our prostate cancer won't cause to our loved ones. Eventually is a collection of first person video testimonials about significant loss and bereavement. In each account, participants reflect upon their own experience, [...]
Some Doctors are Reluctant To Take On ACA Exchange-Plan Patients
According to an article in today’s USA Today, many more doctors will not be accepting medical insurance plans offered through Affordable Care Act exchanges. The reason cited is that these plans often have lower reimbursement [...]
Day 25 of Xofigo shutdown
Day 25 of Xofigo shutdown. We're hearing from men who have lost the opportunity to continue their treatment on schedule. We're hearing from deeply worried spouses. We want to hear from you, too. Malecare continues [...]
Europe Awaits Xtandi – A Positive CHMP Opinion on the Clearance of Enzalutamide In the Pre-Chemotherapy Stage of Prostate Cancer
Some good news for my European brothers, the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has adapted a positive opinion in support of the label expansion of enzalutamide (XTANDI) to include [...]
Updated Overall Survival (OS) Data from a Phase 3 Trial of Ipilimumab (Ipi) vs. Placebo in Men Post Chemotherapy
In a poster presentation at the recent European Society of Medical Oncologists (ESMO) there was a very interesting poster presented updating a phase 3 clinical trial (CA184-043) which evaluated the overall survival (OS) with radiotherapy [...]
Bayer Issues a Formal Statement About the Halting of the Production of Xofigo (Radium Ra 223 Dichloride)
Its day 20 since Xofigo production stopped. How are you? Please email Joel at joel@malecare.org about how the Xofigo shutdown has affected your life. Bayer has issued a public statement about the shortage of Xofigo [...]